cyclo(prolylglycyl) has been researched along with quinoxalines in 1 studies
Studies (cyclo(prolylglycyl)) | Trials (cyclo(prolylglycyl)) | Recent Studies (post-2010) (cyclo(prolylglycyl)) | Studies (quinoxalines) | Trials (quinoxalines) | Recent Studies (post-2010) (quinoxalines) |
---|---|---|---|---|---|
48 | 0 | 28 | 9,887 | 625 | 3,095 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Alyaeva, AG; Gudasheva, TA; Koliasnikova, KN; Povarnina, PY; Seredenin, SB; Vorontsova, ON | 1 |
1 other study(ies) available for cyclo(prolylglycyl) and quinoxalines
Article | Year |
---|---|
The Anxiolytic Effect of the Neuropeptide Cycloprolylglycine Is Mediated by AMPA and TrkB Receptors.
Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Brain-Derived Neurotrophic Factor; Carbazoles; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Indole Alkaloids; Male; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Peptides, Cyclic; Protein-Tyrosine Kinases; Quinoxalines; Receptors, AMPA | 2020 |